A detailed history of Dimensional Fund Advisors LP transactions in Biote Corp. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 678,459 shares of BTMD stock, worth $4.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
678,459
Previous 660,069 2.79%
Holding current value
$4.1 Million
Previous $4.93 Million 23.23%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$5.33 - $8.36 $98,018 - $153,740
18,390 Added 2.79%
678,459 $3.79 Million
Q2 2024

Aug 09, 2024

BUY
$5.44 - $7.47 $3.27 Million - $4.49 Million
600,956 Added 1016.62%
660,069 $4.93 Million
Q1 2024

May 10, 2024

SELL
$3.79 - $6.91 $66,245 - $120,779
-17,479 Reduced 22.82%
59,113 $342,000
Q4 2023

Feb 07, 2024

BUY
$4.43 - $5.81 $111,206 - $145,848
25,103 Added 48.75%
76,592 $378,000
Q3 2023

Nov 09, 2023

BUY
$4.73 - $7.83 $243,542 - $403,158
51,489 New
51,489 $263,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $45.7M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.